JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the offering of Uncapped Dual Directional Buffered Return Enhanced Notes, which are linked to the performance of the lesser performing of the Russell 2000 Index and the S&P 500 Index. These structured investments are designed for investors seeking a return of at least 1.27 times any appreciation or a capped return equal to the absolute value of any depreciation, up to a 15% buffer amount, of the referenced indices at maturity. The notes, which are unsecured and unsubordinated obligations, are fully and unconditionally guaranteed by JPMorgan Chase & Co. The offering is subject to completion, with an expected pricing date on or about August 30, 2024, and a settlement date on...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the offering of Uncapped Dual Directional Buffered Return Enhanced Notes, which are linked to the performance of the lesser performing of the Russell 2000 Index and the S&P 500 Index. These structured investments are designed for investors seeking a return of at least 1.27 times any appreciation or a capped return equal to the absolute value of any depreciation, up to a 15% buffer amount, of the referenced indices at maturity. The notes, which are unsecured and unsubordinated obligations, are fully and unconditionally guaranteed by JPMorgan Chase & Co. The offering is subject to completion, with an expected pricing date on or about August 30, 2024, and a settlement date on or about September 5, 2024. The notes are expected to mature on September 2, 2027. Investors are warned of the risks involved, including the potential loss of up to 85% of their principal if the indices perform poorly, and the lack of guaranteed interest or dividend payments. The notes are not bank deposits, are not FDIC insured, and involve a number of risks detailed in the accompanying prospectus supplement and product supplement. The SEC has not approved or disapproved of the notes nor passed upon the accuracy or adequacy of the preliminary pricing supplement.